For instance, MMP-19 was shown to have adverse effects on fibrosis depending on the signaling pathway in some studies [12,163,168], and mice lacking MMP-19 showed more severe symptoms of IPF suggesting MMP-19 could act as a major regulator in pulmonary fibrosis [169]. This evidence concerns the gene MMP19 and idiopathic pulmonary fibrosis.